应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06127 昭衍新药
耶稣受难节休市 03-28 16:08:03
9.170
+0.060
+0.66%
最高
9.340
最低
9.090
成交量
84.94万
今开
9.110
昨收
9.110
日振幅
2.74%
总市值
68.76亿
流通市值
10.91亿
总股本
7.50亿
成交额
781.03万
换手率
0.71%
流通股本
1.19亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
昭衍新药(06127)将于8月30日派发末期股息每股0.16元
智通财经 · 02:25
昭衍新药(06127)将于8月30日派发末期股息每股0.16元
图解昭衍新药年报:第四季度单季净利润同比减84.31%
证券之星 · 01:32
图解昭衍新药年报:第四季度单季净利润同比减84.31%
昭衍新药(06127)公布2023年业绩 归母净利约3.97亿元 同比减少63.04% 每10股派1.6元
智通财经 · 00:41
昭衍新药(06127)公布2023年业绩 归母净利约3.97亿元 同比减少63.04% 每10股派1.6元
昭衍新药:2023年度净利润约3.97亿元 同比下降63.04%
每日经济新闻 · 00:32
昭衍新药:2023年度净利润约3.97亿元 同比下降63.04%
昭衍新药(06127)拟派发2023年度现金红利每股0.16元
智通财经 · 03-28 23:50
昭衍新药(06127)拟派发2023年度现金红利每股0.16元
昭衍新药最新公告:2023年净利润3.97亿元 拟10派1.6元
证券之星 · 03-28 19:20
昭衍新药最新公告:2023年净利润3.97亿元 拟10派1.6元
昭衍新药(603127.SH)发2023年业绩,净利润3.97亿元,同比下降63.04%
智通财经 · 03-28 17:55
昭衍新药(603127.SH)发2023年业绩,净利润3.97亿元,同比下降63.04%
昭衍新药:拟0.5亿元-1亿元回购公司股份
财通社 · 03-28 17:54
昭衍新药:拟0.5亿元-1亿元回购公司股份
北向资金3月27日净卖出昭衍新药31.55万股 连续3日减持
自选股智能写手 · 03-28 09:30
北向资金3月27日净卖出昭衍新药31.55万股 连续3日减持
智通AH统计|3月27日
智通财经 · 03-27 16:15
智通AH统计|3月27日
昭衍新药03月25日主力资金流出20万元 连续3日减仓
自选股智能写手 · 03-25
昭衍新药03月25日主力资金流出20万元 连续3日减仓
智通AH统计|3月25日
智通财经 · 03-25
智通AH统计|3月25日
昭衍新药(603127)3月22日主力资金净卖出3195.45万元
证券之星 · 03-23
昭衍新药(603127)3月22日主力资金净卖出3195.45万元
昭衍新药03月22日遭主力抛售176万元 环比增加188.52%
自选股智能写手 · 03-22
昭衍新药03月22日遭主力抛售176万元 环比增加188.52%
智通AH统计|3月22日
智通财经 · 03-22
智通AH统计|3月22日
昭衍新药盘中异动 早盘快速跳水5.11%报9.120港元
自选股智能写手 · 03-22
昭衍新药盘中异动 早盘快速跳水5.11%报9.120港元
港股异动 | CRO概念股早盘普跌 药明康德预计今年营收增速创十年新低 花旗称指引令人失望
智通财经 · 03-22
港股异动 | CRO概念股早盘普跌 药明康德预计今年营收增速创十年新低 花旗称指引令人失望
昭衍新药获融资买入0.51亿元,近三日累计买入2.25亿元
金融界 · 03-21
昭衍新药获融资买入0.51亿元,近三日累计买入2.25亿元
智通AH统计|3月20日
智通财经 · 03-20
智通AH统计|3月20日
昭衍新药盘中异动 下午盘大幅下挫5.05%
自选股智能写手 · 03-19
昭衍新药盘中异动 下午盘大幅下挫5.05%
暂无数据
公司概况
公司名称:
昭衍新药
所属市场:
SEHK
上市日期:
--
主营业务:
北京昭衍新药研究中心股份有限公司是一家主要从事新药药理毒理学研究的中国公司。非临床研究服务包括药物安全性评价、药代动力学研究以及药理和药效学研究。临床试验及相关服务包括临床合同研究组织服务、一期临床研究协作单位 (CRU),以及生物分析服务。实验模型业务主要包括啮齿类及非人灵长类动物。该公司在国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"昭衍新药","latestPrice":9.17,"timestamp":1711613283019,"preClose":9.11,"halted":0,"volume":849391,"delay":0,"floatShares":118995206,"shares":749888699,"eps":1.5487174,"marketStatus":"耶稣受难节休市","marketStatusCode":7,"change":0.06,"latestTime":"03-28 16:08:03","open":9.11,"high":9.34,"low":9.09,"amount":7810320,"amplitude":0.027442,"askPrice":9.17,"askSize":700,"bidPrice":9.12,"bidSize":8900,"shortable":3,"etf":0,"ttmEps":1.1130830764029644,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1712021400000},"adr":0,"listingDate":1614268800000,"adjPreClose":9.11,"dividendRate":0.033585,"openAndCloseTimeList":[[1711589400000,1711598400000],[1711602000000,1711612800000]],"volumeRatio":0.6662832921562684,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06127/tweets","defaultTab":"tweets","newsList":[{"id":"2423144366","title":"昭衍新药(06127)将于8月30日派发末期股息每股0.16元","url":"https://stock-news.laohu8.com/highlight/detail?id=2423144366","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2423144366?lang=zh_cn&edition=full","pubTime":"2024-03-29 02:25","pubTimestamp":1711650324,"startTime":"0","endTime":"0","summary":"智通财经APP讯,昭衍新药(06127)发布公告,该公司将于2024年8月30日派发末期股息每股人民币0.16元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1095908.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2423145784","title":"图解昭衍新药年报:第四季度单季净利润同比减84.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2423145784","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2423145784?lang=zh_cn&edition=full","pubTime":"2024-03-29 01:32","pubTimestamp":1711647149,"startTime":"0","endTime":"0","summary":"证券之星消息,昭衍新药2023年年报显示,公司主营收入23.76亿元,同比上升4.78%;归母净利润3.97亿元,同比下降63.04%;扣非净利润3.38亿元,同比下降66.89%;其中2023年第四季度,公司单季度主营收入7.89亿元,同比下降20.39%;单季度归母净利润6939.42万元,同比下降84.31%;单季度扣非净利润2647.65万元,同比下降93.6%;负债率17.41%,投资收益962.78万元,财务费用-1.51亿元,毛利率42.62%。财报数据概要请见下图:以上内容由证券之星根据公开信息整理,由算法生成,与本站立场无关。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403290133448b6ebf6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403290133448b6ebf6d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2423111047","title":"昭衍新药(06127)公布2023年业绩 归母净利约3.97亿元 同比减少63.04% 每10股派1.6元","url":"https://stock-news.laohu8.com/highlight/detail?id=2423111047","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2423111047?lang=zh_cn&edition=full","pubTime":"2024-03-29 00:41","pubTimestamp":1711644085,"startTime":"0","endTime":"0","summary":"智通财经APP讯,昭衍新药(06127)公布2023年业绩,营业收入约23.76亿元,同比增长4.78%;归属于上市公司股东的净利润约3.97亿元,同比减少63.04%;基本每股收益0.53元,每10股派发现金红利1.6元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1095718.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2423110941","title":"昭衍新药:2023年度净利润约3.97亿元 同比下降63.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2423110941","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2423110941?lang=zh_cn&edition=full","pubTime":"2024-03-29 00:32","pubTimestamp":1711643525,"startTime":"0","endTime":"0","summary":"昭衍新药(SH603127,收盘价:18.53元)3月29日发布年度业绩报告称,2023年营业收入约23.76亿元,同比增加4.78%;归属于上市公司股东的净利润约3.97亿元,同比减少63.04%;基本每股收益0.53元,同比减少63.19%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202403293028308019.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202403293028308019.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422143441","title":"昭衍新药(06127)拟派发2023年度现金红利每股0.16元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422143441","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422143441?lang=zh_cn&edition=full","pubTime":"2024-03-28 23:50","pubTimestamp":1711641004,"startTime":"0","endTime":"0","summary":"智通财经APP讯,昭衍新药(06127)发布公告,拟派发2023年度现金红利每股人民币0.16元(含税)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1095632.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422618301","title":"昭衍新药最新公告:2023年净利润3.97亿元 拟10派1.6元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422618301","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2422618301?lang=zh_cn&edition=full","pubTime":"2024-03-28 19:20","pubTimestamp":1711624854,"startTime":"0","endTime":"0","summary":"昭衍新药公布2023年年度报告,报告期实现营业收入23.76亿元,同比增长4.78%;归属于上市公司股东的净利润3.97亿元。拟以实施利润分配方案时股权登记日扣除公司回购专用账户上已回购股份后的总股本为基数,向全体股东每10股派发现金红利1.6元(含税)。以上内容由证券之星根据公开信息整理,由算法生成,与本站立场无关。证券之星力求但不保证该信息(包括但不限于文字、视频、音频、数据及图表)全部或者部分内容的的准确性、完整性、有效性、及时性等,如存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024032800035830.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422157502","title":"昭衍新药(603127.SH)发2023年业绩,净利润3.97亿元,同比下降63.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422157502","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422157502?lang=zh_cn&edition=full","pubTime":"2024-03-28 17:55","pubTimestamp":1711619734,"startTime":"0","endTime":"0","summary":"智通财经APP讯,昭衍新药(603127.SH)发布2023年年度报告,实现营业收入23.76亿元,同比增长4.78%。实现归属于上市公司股东的净利润3.97亿元,同比下降63.04%。实现归属于上市公司股东的扣除非经常性损益的净利润3.38亿元,同比下降66.89%。向全体股东每10股派发现金红利1.6元(含税)。公司归属于上市公司股东的扣除非经常性损益的净利润主要源于实验室服务业务利润和资金管理收益,以及生物资产市价波动的共同影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1094846.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422150302","title":"昭衍新药:拟0.5亿元-1亿元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2422150302","media":"财通社","top":-1,"share":"https://www.laohu8.com/m/news/2422150302?lang=zh_cn&edition=full","pubTime":"2024-03-28 17:54","pubTimestamp":1711619640,"startTime":"0","endTime":"0","summary":"昭衍新药公告,拟0.5亿元-1亿元回购公司股份,回购价不超过董事会通过回购决议前30个交易日公司股票交易均价的150%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032817551187c02465&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032817551187c02465&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422096905","title":"北向资金3月27日净卖出昭衍新药31.55万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2422096905","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422096905?lang=zh_cn&edition=full","pubTime":"2024-03-28 09:30","pubTimestamp":1711589427,"startTime":"0","endTime":"0","summary":"3月27日,北向资金减持昭衍新药31.55万股连续3日减持。截止当日收盘,沪股通共持有昭衍新药843.45万股,占流通股1.33%。沪股通减持金额前五个股分别为长电科技、洛阳钼业、万华化学、中国中免、药明康德。昭衍新药近5个交易日下跌8.30%,沪股通累计减持79.40万股;近20个交易日上涨3.56%,沪股通累计减持321.92万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280944088b6b9495&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280944088b6b9495&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422956036","title":"智通AH统计|3月27日","url":"https://stock-news.laohu8.com/highlight/detail?id=2422956036","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422956036?lang=zh_cn&edition=full","pubTime":"2024-03-27 16:15","pubTimestamp":1711527306,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示,截止3月27日收盘,东北电气、弘业期货、浙江世宝分列AH溢价率前三位,溢价率分别为1144.24%、727.48%、702.51%;紫金矿业、招商银行、海尔智家分列AH溢价率末三位,溢价率分别为22.75%、25.01%、26.58%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1093309.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422625915","title":"昭衍新药03月25日主力资金流出20万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2422625915","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422625915?lang=zh_cn&edition=full","pubTime":"2024-03-25 16:16","pubTimestamp":1711354572,"startTime":"0","endTime":"0","summary":"03月25日, 昭衍新药股价涨0.33%,报收9.13元,成交金额1039万元,换手率0.94%,振幅3.52%,量比0.50。昭衍新药今日主力资金净流出20万元,连续3日净流出,上一交易日主力净流出176万元,今日环比减少88.64%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为66.67%,平均跌幅为3.64%。该股近5个交易日下跌12.95%,主力资金累计净流出193万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入69万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403251616398b603353&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403251616398b603353&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422564204","title":"智通AH统计|3月25日","url":"https://stock-news.laohu8.com/highlight/detail?id=2422564204","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422564204?lang=zh_cn&edition=full","pubTime":"2024-03-25 16:15","pubTimestamp":1711354506,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示,截止3月25日收盘,东北电气、弘业期货、浙江世宝分列AH溢价率前三位,溢价率分别为1121.72%、744.44%、715.00%;比亚迪股份、紫金矿业、海尔智家分列AH溢价率末三位,溢价率分别为21.60%、22.09%、24.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1091402.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2421989805","title":"昭衍新药(603127)3月22日主力资金净卖出3195.45万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421989805","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2421989805?lang=zh_cn&edition=full","pubTime":"2024-03-23 09:07","pubTimestamp":1711156063,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年3月22日收盘,昭衍新药报收于18.73元,下跌4.05%,换手率2.64%,成交量16.66万手,成交额3.16亿元。融券方面,融券卖出7.93万股,融券偿还3.06万股,融券余量117.15万股,融券余额2194.14万元。证券之星力求但不保证该信息全部或者部分内容的的准确性、完整性、有效性、及时性等,如存在问题请联系我们。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024032300018213.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2421632488","title":"昭衍新药03月22日遭主力抛售176万元 环比增加188.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421632488","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421632488?lang=zh_cn&edition=full","pubTime":"2024-03-22 16:15","pubTimestamp":1711095314,"startTime":"0","endTime":"0","summary":"03月22日, 昭衍新药股价跌5.31%,报收9.10元,成交金额1336万元,换手率1.22%,振幅6.14%,量比0.46。昭衍新药今日主力资金净流出176万元,上一交易日主力净流出61万元,今日环比增加188.52%。该股近5个交易日下跌9.36%,主力资金累计净流入161万元;近20日主力资金累计净流入264万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403221615268b54d37e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403221615268b54d37e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421786361","title":"智通AH统计|3月22日","url":"https://stock-news.laohu8.com/highlight/detail?id=2421786361","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2421786361?lang=zh_cn&edition=full","pubTime":"2024-03-22 16:15","pubTimestamp":1711095306,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示,截止3月22日收盘,东北电气、弘业期货、浙江世宝分列AH溢价率前三位,溢价率分别为1121.72%、756.93%、719.62%;紫金矿业、比亚迪股份、海尔智家分列AH溢价率末三位,溢价率分别为21.09%、21.43%、23.22%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1090442.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2421389128","title":"昭衍新药盘中异动 早盘快速跳水5.11%报9.120港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421389128","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421389128?lang=zh_cn&edition=full","pubTime":"2024-03-22 10:52","pubTimestamp":1711075936,"startTime":"0","endTime":"0","summary":"2024年03月22日早盘10时52分,昭衍新药股票出现异动,股价急速下跌5.11%。截至发稿,该股报9.120港元/股,成交量86.36万股,换手率0.73%,振幅5.10%。资金方面,该股资金流入140.084万港元,流出450.921万港元。昭衍新药股票所在的生物技术行业中,整体跌幅为1.55%。其相关个股中,宜明昂科-B、华康生物医学、荃信生物-B涨幅较大,振幅较大的相关个股有宜明昂科-B、药明巨诺-B、圣诺医药-B,振幅分别为37.16%、16.26%、13.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322105216791c2926&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322105216791c2926&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421429887","title":"港股异动 | CRO概念股早盘普跌 药明康德预计今年营收增速创十年新低 花旗称指引令人失望","url":"https://stock-news.laohu8.com/highlight/detail?id=2421429887","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2421429887?lang=zh_cn&edition=full","pubTime":"2024-03-22 10:32","pubTimestamp":1711074732,"startTime":"0","endTime":"0","summary":"消息面上,药明康德此前公告,预计2024年收入383亿元至405亿元,相比2023年全年增长-5.06%至0.39%。即使按照乐观预计的405亿元计算,公司营收增速也将创下近十年以来的新低。中泰国际表示,预计药明康德2024-25年收入将逊于早先预期。花旗发布研报称,药明康德今年的指引令人失望,进一步削弱市场信心,反映增长前景不明确。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1090302.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2421084496","title":"昭衍新药获融资买入0.51亿元,近三日累计买入2.25亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421084496","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2421084496?lang=zh_cn&edition=full","pubTime":"2024-03-21 08:21","pubTimestamp":1710980503,"startTime":"0","endTime":"0","summary":"3月20日,沪深两融数据显示,昭衍新药获融资买入额0.51亿元,居两市第180位,当日融资偿还额0.44亿元,净买入704.11万元。最近三个交易日,18日-20日,昭衍新药分别获融资买入1.05亿元、0.70亿元、0.51亿元。融券方面,当日融券卖出14.87万股,净买入16.33万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403210821568b4e5935&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403210821568b4e5935&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420919167","title":"智通AH统计|3月20日","url":"https://stock-news.laohu8.com/highlight/detail?id=2420919167","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2420919167?lang=zh_cn&edition=full","pubTime":"2024-03-20 16:15","pubTimestamp":1710922507,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示,截止3月20日收盘,东北电气、弘业期货、浙江世宝分列AH溢价率前三位,溢价率分别为1127.27%、766.19%、696.74%;海尔智家、比亚迪股份、紫金矿业分列AH溢价率末三位,溢价率分别为21.68%、21.72%、21.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1088994.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2420175291","title":"昭衍新药盘中异动 下午盘大幅下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420175291","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420175291?lang=zh_cn&edition=full","pubTime":"2024-03-19 14:10","pubTimestamp":1710828644,"startTime":"0","endTime":"0","summary":"2024年03月19日下午盘14时10分,昭衍新药股票出现波动,股价急速跳水5.05%。截至发稿,该股报9.971港元/股,成交量195.618万股,换手率1.64%,振幅4.86%。昭衍新药股票所在的生物技术行业中,整体跌幅为0.78%。其相关个股中,科伦博泰生物-B、帝王国际投资、华领医药-B涨幅较大,振幅较大的相关个股有嘉和生物-B、东曜药业-B、腾盛博药-B,振幅分别为12.50%、11.46%、10.48%。消息层面,截至14时10分,昭衍新药股票正面舆情新闻比例33.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031914104487e79fd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031914104487e79fd9&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0458},{"period":"1month","weight":-0.1045},{"period":"3month","weight":-0.2869},{"period":"6month","weight":-0.3403},{"period":"1year","weight":-0.5738},{"period":"ytd","weight":-0.2869}],"compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0149},{"period":"3month","weight":-0.0297},{"period":"6month","weight":-0.0712},{"period":"1year","weight":-0.1808},{"period":"ytd","weight":-0.0297}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京昭衍新药研究中心股份有限公司是一家主要从事新药药理毒理学研究的中国公司。非临床研究服务包括药物安全性评价、药代动力学研究以及药理和药效学研究。临床试验及相关服务包括临床合同研究组织服务、一期临床研究协作单位 (CRU),以及生物分析服务。实验模型业务主要包括啮齿类及非人灵长类动物。该公司在国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.116163},{"month":2,"riseRate":0.666667,"avgChangeRate":-0.004244},{"month":3,"riseRate":0.25,"avgChangeRate":-0.02162},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.055351},{"month":5,"riseRate":0.666667,"avgChangeRate":0.032398},{"month":6,"riseRate":0.666667,"avgChangeRate":0.066228},{"month":7,"riseRate":1,"avgChangeRate":0.051077},{"month":8,"riseRate":0,"avgChangeRate":-0.202169},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.126744},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.049121},{"month":11,"riseRate":0.333333,"avgChangeRate":0.093591},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.082054}],"exchange":"SEHK","name":"昭衍新药","nameEN":"JOINN"},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,06127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}